Theratechnologies Inc. Capital Reinvestment Ratio

Latest as of May 2025: 3.80x

Theratechnologies Inc. capital reinvestment ratio. Theratechnologies Inc. (TH) has a Capital Reinvestment Ratio of 3.80x as of May 2025, meaning it reinvests 4% of its operating cash flow (CA$2.66 Million) in capital expenditures (CA$10.11 Million). Check how aggressively does Theratechnologies Inc. reinvest cash to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

3.80x
Capex / Operating Cash Flow

Operating Cash Flow

CA$2.66 Million
CAD

Capital Expenditures

CA$10.11 Million
CAD

Data as of

May 2025
Most recent filing

Capital Reinvestment Ratio of Theratechnologies Inc. (2009–2024)

Capital reinvestment ratio of Theratechnologies Inc. from 2009 to 2024. This chart tracks Theratechnologies Inc.'s Capital Reinvestment Ratio across 6 annual periods. Also explore Theratechnologies Inc. (TH) net asset momentum to track the company's year-over-year net asset growth rate.

Theratechnologies Inc. Capital Reinvestment Ratio by Year (2009–2024)

Theratechnologies Inc. capital reinvestment ratio by year from 2009 to 2024. For the full cash flow conversion analysis, see how efficiently does Theratechnologies Inc. generate cash.

Year Reinvestment Ratio Operating CF (CAD) Capital Expenditures YoY Change
2024 0.63x CA$2.38 Million CA$1.50 Million ▲ +1529.4%
2017 0.04x CA$1.91 Million CA$73.82K ▼ -93.5%
2016 0.59x CA$2.00 Million CA$1.19 Million ▲ +10058.0%
2015 0.01x CA$5.30 Million CA$31.00K ▼ -95.9%
2010 0.14x CA$2.84 Million CA$407.05K ▲ +98.9%
2009 0.07x CA$5.35 Million CA$384.80K —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow